What are the echocardiographic findings in hypertrophic obstructive cardiomyopathy?

Echocardiographic Findings in Hypertrophic Obstructive Cardiomyopathy

Comprehensive 2D echocardiography is the primary imaging modality for diagnosing HOCM and should demonstrate asymmetric septal hypertrophy (≥15mm or ≥13mm with family history), systolic anterior motion (SAM) of the mitral valve, left ventricular outflow tract (LVOT) obstruction with peak gradient ≥30 mmHg, and secondary mitral regurgitation. 1

Key Structural Findings

Left Ventricular Hypertrophy Pattern

• Asymmetric septal hypertrophy is the hallmark finding, with interventricular septum thickness ≥1.4 cm and a septal-to-posterior wall thickness ratio ≥1.4 2, 3
• The most common pattern (52% of patients) involves both the ventricular septum and anterolateral free wall (Type III distribution), which correlates with more severe functional limitation and higher likelihood of resting obstruction 2
• Maximal wall thickness documentation is essential as it informs phenotype severity and sudden cardiac death risk stratification 1

Chamber Dimensions

• Smaller telesystolic diameter of the left ventricle is characteristic in obstructive HCM (22±6 mm in OHCM vs 26±5 mm in non-obstructive) 4
• Left ventricular cavity size may be significantly compromised in patients with severe hypertrophy and restrictive physiology 1
• Left atrial enlargement is commonly present due to elevated filling pressures 4

Dynamic Obstruction Features

LVOT Gradient Assessment

• Obstruction is defined as peak LVOT gradient ≥30 mmHg, with gradients ≥50 mmHg considered hemodynamically significant and warranting consideration for advanced therapies if symptoms are refractory 1
• Provocative maneuvers are mandatory if resting gradient is <50 mmHg, as up to 50% of patients with obstructive physiology are missed on resting echocardiography alone 1
• Standing, Valsalva strain, or exercise echocardiography should be performed to unmask latent obstruction; dobutamine provocation is not recommended due to lack of specificity 1

Systolic Anterior Motion (SAM)

• SAM of the mitral valve is the primary mechanism causing dynamic LVOT obstruction and is observed in 89% of obstructive cases versus only 38% of non-obstructive cases 4
• SAM is characterized by a large backward component in late systole with extreme approximation to the interventricular septum at its peak 3
• Severe SAM is an independent predictor of favorable outcome after septal myectomy 5

Mitral Valve Abnormalities

Mitral Regurgitation

• Secondary MR from SAM occurs in 78% of obstructive HCM patients versus only 19% in non-obstructive cases 4
• The MR jet is typically mid-to-late systolic and directed posteriorly or laterally due to anterior distortion of the mitral valve and compromised leaflet coaptation, though central and anterior jets can also occur 1
• Close examination of the mitral valve is required before contemplating septal reduction therapy to determine optimal approach 1

Primary Mitral Valve Abnormalities

• Elongated mitral leaflets with increased overall valve size are common, with mitral valve opening area correlating strongly with actual leaflet area (r=0.87) 6
• Anomalous papillary muscle insertion and anteriorly displaced papillary muscles are frequently present 1
• Mitral annular calcification occurs more frequently in obstructive HCM (44% vs 15% in non-obstructive) 4

Diastolic Dysfunction Parameters

Abnormal Filling Patterns

• Reduced rate of diastolic descent of the mitral valve (DDR) correlates with abnormal left atrio-ventricular flow patterns (r=0.79) 3
• Prolonged isovolumetric relaxation time is an independent predictor of favorable response to septal myectomy 5
• Mean diastolic posterior wall velocity (mPWVd) and mean rapid filling rate (mRFR) are characteristically reduced, with mRFR correlating with negative maximum dp/dt (r=0.68) 3
• Diastolic dysfunction can be identified even in young sarcomere gene variant carriers with normal wall thickness, representing an early manifestation 1

Additional Echocardiographic Considerations

Site of Obstruction Characterization

• Management differs based on whether obstruction is valvular, dynamic LVOTO, fixed subvalvular, or midcavitary due to hypertrophied/anomalous papillary muscles with systolic cavity obliteration 1
• Transesophageal echocardiography (TEE) is standard during surgical myectomy to assess mitral valve abnormalities, extent of septal hypertrophy, and monitor for complications including ventricular septal defect or new aortic insufficiency 1

Post-Intervention Assessment

• Following septal reduction therapy, echocardiography should assess septal thinning, LVOT gradient reduction, residual SAM, mitral regurgitation, aortic insufficiency, and ventricular septal defect 1
• Ultrasound-enhancing agents during alcohol septal ablation have resulted in greater procedural success, decreased intervention time, smaller infarct size, and lower heart block rates 1